{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:04Z","timestamp":1707524464503},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,16]]},"DOI":"10.7759\/cureus.21302","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T06:21:49Z","timestamp":1642400509000},"source":"Crossref","is-referenced-by-count":3,"title":["COVID-19 and Liver Dysfunction"],"prefix":"10.7759","author":[{"given":"Nour","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jad","family":"Hosri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yara","family":"Bteich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Dib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Abou Rached","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Monitoring of COVID-19 infection in Lebanon. (2021). Accessed. December 2021: https:\/\/www.moph.gov.lb\/en\/DynamicPages\/index\/127\/43750\/monitoring-of-covid-19-."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.20-0986","article-title":"Extrapulmonary clinical manifestations in COVID-19 patients","volume":"103","author":"Sarkesh A","year":"2020","unstructured":"Sarkesh A, Daei Sorkhabi A, Sheykhsaran E, Alinezhad F, Mohammadzadeh N, Hemmat N, Bannazadeh Baghi H. Extrapulmonary clinical manifestations in COVID-19 patients. Am J Trop Med Hyg. 2020, 103:1783-96. 10.4269\/ajtmh.20-0986","journal-title":"Am J Trop Med Hyg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26294","article-title":"Extrapulmonary complications of COVID-19: a multisystem disease?","volume":"93","author":"Zheng KI","year":"2021","unstructured":"Zheng KI, Feng G, Liu WY, Targher G, Byrne CD, Zheng MH. Extrapulmonary complications of COVID-19: a multisystem disease?. J Med Virol. 2021, 93:323-35. 10.1002\/jmv.26294","journal-title":"J Med Virol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00373-7","article-title":"COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms","volume":"5","author":"Zhong P","year":"2020","unstructured":"Zhong P, Xu J, Yang D, et al.. COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms. Signal Transduct Target Ther. 2020, 5:256. 10.1038\/s41392-020-00373-7","journal-title":"Signal Transduct Target Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14565","article-title":"Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19","volume":"40","author":"Piano S","year":"2020","unstructured":"Piano S, Dalbeni A, Vettore E, et al.. Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19. Liver Int. 2020, 40:2394-406. 10.1111\/liv.14565","journal-title":"Liver Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31301","article-title":"Longitudinal association between markers of liver injury and mortality in COVID-19 in China","volume":"72","author":"Lei F","year":"2020","unstructured":"Lei F, Liu YM, Zhou F, et al.. Longitudinal association between markers of liver injury and mortality in COVID-19 in China. Hepatology. 2020, 72:389-98. 10.1002\/hep.31301","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","volume":"5","author":"Zhang C","year":"2020","unstructured":"Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020, 5:428-30. 10.1016\/S2468-1253(20)30057-1","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-021-07007-0","article-title":"Increased morbidity and mortality in COVID-19 patients with liver injury","author":"Siddiqui MA","year":"2021","unstructured":"Siddiqui MA, Suresh S, Simmer S, et al..  Increased morbidity and mortality in COVID-19 patients with liver injury. Dig Dis Sci. 2021, 1-7. 10.1007\/s10620-021-07007-0","journal-title":"Dig Dis Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31487","article-title":"Abnormal liver tests in COVID-19: a retrospective observational cohort study of 1,827 patients in a major U.S. hospital network","volume":"72","author":"Hundt MA","year":"2020","unstructured":"Hundt MA, Deng Y, Ciarleglio MM, Nathanson MH, Lim JK. Abnormal liver tests in COVID-19: a retrospective observational cohort study of 1,827 patients in a major U.S. hospital network. Hepatology. 2020, 72:1169-76. 10.1002\/hep.31487","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/2050640620924157","article-title":"Liver injury in COVID-19: the current evidence","volume":"8","author":"Alqahtani SA","year":"2020","unstructured":"Alqahtani SA, Schattenberg JM. Liver injury in COVID-19: the current evidence. United European Gastroenterol J. 2020, 8:509-19. 10.1177\/2050640620924157","journal-title":"United European Gastroenterol J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2021.0573","article-title":"Prevailing patterns of liver enzymes in patients with COVID-19 infection and association with clinical outcomes","volume":"34","author":"Yadlapati S","year":"2021","unstructured":"Yadlapati S, Lo KB, DeJoy R, et al.. Prevailing patterns of liver enzymes in patients with COVID-19 infection and association with clinical outcomes. Ann Gastroenterol. 2021, 34:224-8. 10.20524\/aog.2021.0573","journal-title":"Ann Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: a guide for clinicians","volume":"172","author":"Giannini EG","year":"2005","unstructured":"Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ. 2005, 172:367-79. 10.1503\/cmaj.1040752","journal-title":"CMAJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.07.050","article-title":"Hepatic disorders with the use of remdesivir for coronavirus 2019","volume":"18","author":"Montastruc F","year":"2020","unstructured":"Montastruc F, Thuriot S, Durrieu G. Hepatic disorders with the use of remdesivir for coronavirus 2019. Clin Gastroenterol Hepatol. 2020, 18:2835-6. 10.1016\/j.cgh.2020.07.050","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-020-10077-3","article-title":"Liver injury in remdesivir-treated COVID-19 patients","volume":"14","author":"Zampino R","year":"2020","unstructured":"Zampino R, Mele F, Florio LL, et al.. Liver injury in remdesivir-treated COVID-19 patients. Hepatol Int. 2020, 14:881-3. 10.1007\/s12072-020-10077-3","journal-title":"Hepatol Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S303629","article-title":"Dynamic changes in liver function tests and their correlation with illness severity and mortality in patients with COVID-19: a retrospective cohort study","volume":"16","author":"Xu W","year":"2021","unstructured":"Xu W, Huang C, Fei L, Li Q, Chen L. Dynamic changes in liver function tests and their correlation with illness severity and mortality in patients with COVID-19: a retrospective cohort study. Clin Interv Aging. 2021, 16:675-85. 10.2147\/CIA.S303629","journal-title":"Clin Interv Aging"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15962","article-title":"The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan","volume":"52","author":"Huang H","year":"2020","unstructured":"Huang H, Chen S, Li H, et al.. The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan. Aliment Pharmacol Ther. 2020, 52:1051-9. 10.1111\/apt.15962","journal-title":"Aliment Pharmacol Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103770","article-title":"Elevated lactate dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19","volume":"12","author":"Li C","year":"2020","unstructured":"Li C, Ye J, Chen Q, et al.. Elevated lactate dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19. Aging (Albany NY). 2020, 12:15670-81. 10.18632\/aging.103770","journal-title":"Aging (Albany NY)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S278365","article-title":"Diagnostic performance of a blood urea nitrogen to creatinine ratio-based nomogram for predicting in-hospital mortality in COVID-19 patients","volume":"14","author":"Liu Q","year":"2021","unstructured":"Liu Q, Wang Y, Zhao X, et al.. Diagnostic performance of a blood urea nitrogen to creatinine ratio-based nomogram for predicting in-hospital mortality in COVID-19 patients. Risk Manag Healthc Policy. 2021, 14:117-28. 10.2147\/RMHP.S278365","journal-title":"Risk Manag Healthc Policy"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001585","article-title":"Neutrophil-to-lymphocyte ratio and outcomes in Louisiana COVID-19 patients","volume":"54","author":"Tatum D","year":"2020","unstructured":"Tatum D, Taghavi S, Houghton A, Stover J, Toraih E, Duchesne J. Neutrophil-to-lymphocyte ratio and outcomes in Louisiana COVID-19 patients. Shock. 2020, 54:652-8. 10.1097\/SHK.0000000000001585","journal-title":"Shock"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2020-10-3","article-title":"Current treatment in COVID-19 disease: a rapid review","volume":"10","author":"Rodriguez-Guerra M","year":"2021","unstructured":"Rodriguez-Guerra M, Jadhav P, Vittorio TJ. Current treatment in COVID-19 disease: a rapid review. Drugs Context. 2021, 10:2020-10-3. 10.7573\/dic.2020-10-3","journal-title":"Drugs Context"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2020-001428","article-title":"Coronary artery disease in patients hospitalised with coronavirus disease 2019 (COVID-19) infection","volume":"7","author":"Loffi M","year":"2020","unstructured":"Loffi M, Piccolo R, Regazzoni V, et al.. Coronary artery disease in patients hospitalised with coronavirus disease 2019 (COVID-19) infection. Open Heart. 2020, 7:e001428. 10.1136\/openhrt-2020-001428","journal-title":"Open Heart"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/MCA.0000000000000934","article-title":"The relationship between coronary artery disease and clinical outcomes in COVID-19: a single-center retrospective analysis","volume":"32","author":"Peterson E","year":"2021","unstructured":"Peterson E, Lo KB, DeJoy R, et al.. The relationship between coronary artery disease and clinical outcomes in COVID-19: a single-center retrospective analysis. Coron Artery Dis. 2021, 32:367-71. 10.1097\/MCA.0000000000000934","journal-title":"Coron Artery Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang L","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?. Lancet Respir Med. 2020, 8:e21. 10.1016\/S2213-2600(20)30116-8","journal-title":"Lancet Respir Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13124","article-title":"Renin-angiotensin-aldosterone system inhibitors and COVID-19: a meta-analysis and systematic review","volume":"13","author":"Hassib M","year":"2021","unstructured":"Hassib M, Hamilton S, Elkhouly A, Li Y, Kaplan AC. Renin-angiotensin-aldosterone system inhibitors and COVID-19: a meta-analysis and systematic review. Cureus. 2021, 13:e13124. 10.7759\/cureus.13124","journal-title":"Cureus"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/jim-2020-001641","article-title":"Gender-based disparities in COVID-19 patient outcomes","author":"Marik PE","year":"2021","unstructured":"Marik PE, DePerrior SE, Ahmad Q, Dodani S. Gender-based disparities in COVID-19 patient outcomes. J Investig Med. 2021, 10.1136\/jim-2020-001641","journal-title":"J Investig Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/80052-covid-19-and-liver-dysfunction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:25Z","timestamp":1707507685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/80052-covid-19-and-liver-dysfunction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,16]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.21302","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,16]]}}}